The Institute for Lung Health uncovers the molecular and cellular mechanisms underlying the maintenance of lung health and their failure in lung disease, and develops etiology-based preventive and regenerative therapies.
Research at the ILH focuses on the parenchymal/vascular lung compartment with a strong translational mission. This includes the topics of Resilience, Remodeling, Repair and Regeneration.
An ATS workshop led by ILH scientist Prof. Mareike Lehmann brings together leading experts to advance precision-cut lung slices (PCLS) as a promising tool for the development of targeted therapies.
The analysis of large datasets enables more precise diagnoses, treatment, and even prevention of widespread diseases. The new issue of SYNERGIE describes the research approaches taken by the German Centers for Health Research (DZG).
A research team at Philipps University Marburg has discovered that small vesicles in pulmonary fibrosis transport a protein that impairs the lung's regenerative capacity. This protein could serve as a target for new therapies and as a biomarker for better recognition of the disease.
Our site uses cookies and similar technologies. By using the site, you consent to the use of cookies.
You can find more information on this in our Privacy Policy.
